Latest filing published 30 Nov 2017 for Nexien Biopharma, INC..
Insider track record
No signal scores available.
Intiva USA Inc: trading record in brief
All filings by Intiva USA Inc on record concern Nexien Biopharma, Inc. We count 3 filings; the first trade dates from 13 October 2017 and the latest from 29 November 2017.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 30 November 2017: a transaction, in Nexien Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Intiva USA Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,099,083 sharesCommon StockSEC:0001214659-17-007035:0
- 20,000,000 sharesCommon StockSEC:0001214659-17-006077:0
- 53,405,501 sharesCommon StockSEC:0001214659-17-006077:1
3 of 3 declarations